Basket trials mostly investigate less conventional target, such as EpCAM in EpCAM positive cancer (HCC, gastro-intestinal cancer, liver cancer) (NCT03013712) or Claudin18.2, a protein implied in tight junctions and expressed in digestive tumors (stomach, gastroesophageal junction, pancreas, and liver) (NCT03302403). This evidence concerns the gene EPCAM and liver cancer.